Equity Overview
Price & Market Data
Price: $13.44
Daily Change: -$0.03 / 0.22%
Daily Range: $13.00 - $13.89
Market Cap: $208,521,152
Daily Volume: 564,726
Performance Metrics
1 Week: 3.46%
1 Month: -8.57%
3 Months: -7.82%
6 Months: -7.82%
1 Year: -7.82%
YTD: -7.82%
Company Details
Employees: 511
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.